Lonza and CytoMate Collaboration on CytoSMART™ Technology
News Mar 05, 2015
Lonza and CytoMate Technologies BV have entered into a global distribution agreement for CytoMate’s newly developed CytoSMART™ Technology, which has been designed for easy and affordable live cell imaging. The CytoSMART™ Technology enables researchers to take time-lapse videos and images of their cell culture. The images taken with the CytoSMART™ Device are transmitted to CytoSMART™ Cloud, which permits researchers to view their cell culture outside the lab at any time.
Possible applications of the CytoSMART™ Technology are broad, including using video to document the generation of induced pluripotent stem cells, and migration assays such as scratch assays. The system also lends itself to the monitoring of cell cultures under hypoxic conditions, as well as easy and efficient cell culture standardization.
“The CytoSMART™ Technology is an excellent addition to our existing research portfolio, in particular, our primary cell offering. While elaborate live cell imaging systems have been available to the market for years, solutions that are affordable and easy-to-use have been missing…until now. We are convinced that, thanks to CytoSMART™, almost any lab can take advantage of the numerous possibilities that live cell culture imaging offers,” said Teun van der Heide, Head of Lonza’s Bioscience Solutions business unit.
Joffry Maltha, CEO of CytoMate Technologies BV, commented: “During our own research, we came to understand that there was a need for a system that could offer permanent cell culture monitoring. Just as importantly, it needed to be small, simple to use, affordable for general labs to purchase and able to free researchers from the burden of manually checking their cells on a frequent basis. With our years of experience in the electronics industry, we decided to address the issue and develop a system similar to current smartphone technologies, resulting in the CytoSMART™ offerings. With Lonza, we have found the ideal global distribution partner, which will allow us to gain rapid market access through its existing sales, marketing and distribution channels.”
Scleroderma Study Offers New Hope For SufferersNews
An unusual autoimmune disease that causes skin and lung damage can be treated effectively by stem cell transplant, a new study found. The approach could represent the first new treatment to improve survival in patients with severe scleroderma in more than four decades.READ MORE
Immunosuppressive Cells in Newborns Play Important Role in Controlling Inflammation in Early LifeNews
New research has characterized the transitory presence of myeloid-derived suppressor cells (MDSCs) in mouse and human newborns, revealing a critical role of these cells in regulation of inflammation in the early stages of life.READ MORE
Fast-tracking T Cell Therapies with Immune-mimicking BiomaterialsNews
A new approach to amplify patient-specific T cells outside the body could increase the efficiency of cancer immunotherapies.READ MORE